Package 46708-654-09

{"route": ["SUBCUTANEOUS"], "spl_id": "8c149392-d281-4311-880f-3be2b4752f40", "openfda": {"unii": ["325O8467XK"], "rxcui": ["1148141"], "spl_set_id": ["8c149392-d281-4311-880f-3be2b4752f40"], "manufacturer_name": ["Alembic Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (46708-654-03)  / 3 mL in 1 SYRINGE, GLASS", "package_ndc": "46708-654-03", "marketing_start_date": "20240614"}, {"sample": false, "description": "3 SYRINGE, GLASS in 1 CARTON (46708-654-09)  / 3 mL in 1 SYRINGE, GLASS", "package_ndc": "46708-654-09", "marketing_start_date": "20240614"}], "brand_name": "Icatibant", "product_id": "46708-654_8c149392-d281-4311-880f-3be2b4752f40", "dosage_form": "INJECTION", "pharm_class": ["Bradykinin B2 Receptor Antagonist [EPC]", "Bradykinin B2 Receptor Antagonists [MoA]"], "product_ndc": "46708-654", "generic_name": "Icatibant", "labeler_name": "Alembic Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Icatibant", "active_ingredients": [{"name": "ICATIBANT ACETATE", "strength": "30 mg/3mL"}], "application_number": "ANDA213773", "marketing_category": "ANDA", "marketing_start_date": "20240614", "listing_expiration_date": "20261231"}